地喹氯铵在体外和体内抑制人胶质瘤细胞生长:分子机制与潜在靶向药物研究
本研究探讨地喹氯铵(DECA)对人胶质瘤细胞系的体外和体内抑制作用及其分子机制。通过MTT、基因组DNA电泳、DAPI染色、TUNEL染色和划痕实验评估DECA对胶质瘤细胞的影响,并用生物信息学方法筛选信号通路蛋白。结果显示DECA显著抑制胶质瘤细胞生长和增殖,给药后6个基因的mRNA表达水平显著改变。DECA可能通过影响NFKB2、HRAS、NF1、CBL、RAF1和BCL-2基因表达促进胶质瘤细胞凋亡。
要点
- DECA在体外和体内均显著抑制人胶质瘤细胞生长与增殖。
- DECA给药后6个凋亡相关基因的mRNA表达显著改变。
- DECA可能通过调控NFKB2、HRAS、NF1、CBL、RAF1和BCL-2促进凋亡。
核心结论
- DECA在体外和体内均有效抑制胶质瘤细胞生长。
- DECA可能通过影响NFKB2、HRAS、NF1、CBL、RAF1和BCL-2基因表达促进胶质瘤细胞凋亡。
研究设计与样本
- 研究采用人胶质瘤细胞系进行体外和体内实验,未报告样本量。
- 体外实验使用MTT assay、基因组DNA电泳、DAPI染色、TUNEL染色和划痕实验评估DECA效果。
- 采用生物信息学方法筛选可能信号通路蛋白,并检测相应蛋白及mRNA表达。
主要发现
- DECA显著抑制人胶质瘤细胞生长和增殖。
- 给药后6个凋亡相关基因的mRNA表达水平显著改变。
关键数值与推荐
- DECA给药后6个基因的mRNA表达水平显著改变。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Our current understanding of the role of dequalinium chloride (DECA) in the progression of glioma remains very limited. This study was aimed to investigate the effect of DECA on human glioma cell lines in vitro and vivo. METHODS: The underlying molecular mechanism was analyzed for developing potential targeted agents. MTT assay, genomic DNA electrophoresis, DAPI staining, TUNEL staining, and wound scratch assay were performed to evaluate the effect of DECA on human glioma cell lines. Bioinformatics methods were used to screen the possible signaling pathway proteins, and the expression of these proteins and the corresponding mRNA was measured. RESULTS: DECA significantly inhibited the growth and proliferation of human glioma cells. Screening of apoptosis-related proteins showed the mRNA expression level of 6 genes was significantly changed after DECA administration. CONCLUSION: This study shows that DECA effectively inhibits the growth of glioma cells in vitro and vivo. DECA may promote glioma cell apoptosis by affecting the expression of NFKB2, HRAS, NF1, CBL, RAF1, and BCL-2 genes.
引用
- Yu Y, Yang B, Yu J, et al. Dequalinium chloride inhibits the growth of human glioma cells in vitro and vivo: a study on molecular mechanism and potential targeted agents. Acta Neurochir (Wien). 2020. PMID: 32410120. doi:10.1007/s00701-020-04401-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。